![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 32827 |
FusionGeneSummary for SCG5_HBA2 |
![]() |
Fusion gene information | Fusion gene name: SCG5_HBA2 | Fusion gene ID: 32827 | Hgene | Tgene | Gene symbol | SCG5 | HBA2 | Gene ID | 6447 | 3040 |
Gene name | secretogranin V | hemoglobin subunit alpha 2 | |
Synonyms | 7B2|P7B2|SGNE1|SgV | HBA-T2|HBH | |
Cytomap | 15q13.3 | 16p13.3 | |
Type of gene | protein-coding | protein-coding | |
Description | neuroendocrine protein 7B2pituitary polypeptideprohormone convertase chaperonesecretogranin-5secretory granule endocrine protein Isecretory granule, neuroendocrine protein 1 (7B2 protein) | hemoglobin subunit alphaalpha globinalpha-2 globinhemoglobin alpha chainhemoglobin, alpha 2mutant hemoglobin alpha 2 globin chain | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | P05408 | P69905 | |
Ensembl transtripts involved in fusion gene | ENST00000413748, ENST00000300175, ENST00000494364, ENST00000497208, ENST00000498069, | ENST00000251595, ENST00000397806, | |
Fusion gene scores | * DoF score | 1 X 1 X 1=1 | 3 X 3 X 1=9 |
# samples | 1 | 3 | |
** MAII score | log2(1/1*10)=3.32192809488736 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
Context | PubMed: SCG5 [Title/Abstract] AND HBA2 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Tgene | HBA2 | GO:0010942 | positive regulation of cell death | 19740759 |
Tgene | HBA2 | GO:0042542 | response to hydrogen peroxide | 19740759 |
Tgene | HBA2 | GO:0042744 | hydrogen peroxide catabolic process | 19740759 |
Tgene | HBA2 | GO:0051291 | protein heterooligomerization | 19740759 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChiTaRS3.1 | BP386507 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000413748 | ENST00000251595 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000413748 | ENST00000397806 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000300175 | ENST00000251595 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000300175 | ENST00000397806 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000494364 | ENST00000251595 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000494364 | ENST00000397806 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000497208 | ENST00000251595 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
In-frame | ENST00000497208 | ENST00000397806 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
3UTR-3CDS | ENST00000498069 | ENST00000251595 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
3UTR-3CDS | ENST00000498069 | ENST00000397806 | SCG5 | chr15 | 32972005 | - | HBA2 | chr16 | 223512 | + |
Top |
FusionProtFeatures for SCG5_HBA2 |
![]() |
Hgene | Tgene |
SCG5 | HBA2 |
Acts as a molecular chaperone for PCSK2/PC2, preventingits premature activation in the regulated secretory pathway. Bindsto inactive PCSK2 in the endoplasmic reticulum and facilitates itstransport from there to later compartments of the secretorypathway where it is proteolytically matured and activated. Alsorequired for cleavage of PCSK2 but does not appear to be involvedin its folding. Plays a role in regulating pituitary hormonesecretion. The C-terminal peptide inhibits PCSK2 in vitro.{ECO:0000269|PubMed:7913882}. | Involved in oxygen transport from the lung to thevarious peripheral tissues. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for SCG5_HBA2 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
>In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0aa >In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0aa >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0aa >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0aa >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0aa >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0aa >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0aa >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0aa |
* Fusion transcript sequences (only coding sequence (CDS) region). |
>In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt |
* Fusion transcript sequences (Full-length transcript). |
>In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000413748_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000300175_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000494364_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000251595_chr16_223512_+_0nt >In-frame_SCG5_ENST00000497208_chr15_32972005_-_HBA2_ENST00000397806_chr16_223512_+_0nt |
Top |
FusionGenePPI for SCG5_HBA2 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for SCG5_HBA2 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Tgene | HBA2 | P69905 | DB01592 | Iron | Hemoglobin subunit alpha | small molecule | approved |
Tgene | HBA2 | P69905 | DB09146 | Iron saccharate | Hemoglobin subunit alpha | small molecule | approved |
Tgene | HBA2 | P69905 | DB00358 | Mefloquine | Hemoglobin subunit alpha | small molecule | approved|investigational |
Tgene | HBA2 | P69905 | DB01593 | Zinc | Hemoglobin subunit alpha | small molecule | approved|investigational |
Tgene | HBA2 | P69905 | DB09112 | Nitrous acid | Hemoglobin subunit alpha | small molecule | approved|investigational |
Tgene | HBA2 | P69905 | DB09140 | Oxygen | Hemoglobin subunit alpha | small molecule | approved|vet_approved |
Top |
RelatedDiseases for SCG5_HBA2 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SCG5 | C0009404 | Colorectal Neoplasms | 1 | CTD_human |
Hgene | SCG5 | C0025149 | Medulloblastoma | 1 | CTD_human |
Tgene | HBA2 | C0002312 | alpha-Thalassemia | 2 | CTD_human |
Tgene | HBA2 | C0005283 | beta Thalassemia | 1 | CTD_human |
Tgene | HBA2 | C0263454 | Chloracne | 1 | CTD_human |